Aurobindo Pharma to participate in J.P. Morgan India Investor Conference on September 22
- Aurobindo Pharma officials to attend J.P. Morgan India Investor Conference
- Meetings scheduled for September 22, 2026, in Mumbai
- Sessions include one-on-one and group interactions from 9 am to 5 pm
- No unpublished price sensitive information to be discussed
*this image is generated using AI for illustrative purposes only.
Aurobindo Pharma will participate in the J.P. Morgan India Investor Conference on September 22, 2026, in Mumbai. The company's officials are scheduled for one-on-one and group meetings with investors and analysts.
Meeting details
The interaction is scheduled to take place from 9 am to 5 pm IST. The company has confirmed that no unpublished price sensitive information (UPSI) will be discussed during these sessions.
| Parameter | Details |
|---|---|
| Event | J.P. Morgan India Investor Conference |
| Date | September 22, 2026 |
| Time | 9 am to 5 pm |
| Location | Mumbai |
| Type | One-on-one and group meetings |
Such conferences provide a platform for management to engage directly with the investment community, allowing analysts to seek clarifications on business strategy and performance.
Historical Stock Returns for Aurobindo Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.68% | +2.60% | +1.93% | +30.63% | +59.94% | 0.0% |
How might Aurobindo Pharma's strategic updates at the J.P. Morgan conference influence investor sentiment ahead of its Q1 FY27 earnings release?
Will management provide new guidance on the timeline for regulatory approvals of key generic products in the US and EU markets?
What is the expected impact of ongoing pricing pressures in the US generics market on Aurobindo's gross margins for the next fiscal year?
19
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
